Abstract. The effects of conjugated linoleic acid (CLA) on the levels of total serum leucocytes, granulocytes including neutrophils, basophils, and eosinophils, as well as on monocytes and leucocytes were measured in pigs selected from a clean (minimal disease) herd. Thirty pigs were fed different rates of dietary CLA (0, 1.25, 2.5, 5.0, 7.5, and 10.0 g CLA-55/kg diet) for 8 weeks. Blood samples were collected at the end of the study for assessment of haematological and humoral responses to CLA supplementation. No difference in total white blood cells including the neutrophil, monocyte, and lymphocyte counts was observed among different dietary groups. A dose-dependent reduction (P = 0.02) in eosinophil concentrations suggests that CLA exerts anti-inflammatory activities. A 2-fold increase in the level of basophils was recorded in pigs fed lower levels of CLA (1.25 and 2.5 g CLA/kg diet) but the levels decreased gradually (P = 0.05) and were below the detection limit at the highest rate (10 g/kg) of CLA supplementation. The level of IgG was reduced by over 50% in CLA-fed pigs (P < 0.001), although the response was quadratic in nature (P < 0.001). T-cell population analysis showed that CD4+ cells tended (P = 0.06) to be reduced linearly with increasing inclusion of CLA in the diet. Our results suggest that dietary CLA modulates haematological and humoral responses in a dose-dependent manner.
Introduction
Conjugated linoleic acid (CLA) exerts many positive health effects in experimental models. For example, CLA has been shown to possess anticarcinogenic and antitumorogenic (Ha et al. 1987; Shultz et al. 1992a Shultz et al. , 1992b Ip et al. 1994 Ip et al. , 1999a Ip et al. , 1999b Belury et al. 1996; Cunningham et al. 1997; Cesano et al. 1998) as well as antiatherogenic (Lee et al. 1994; Nicolosi et al. 1997) properties. It has been suggested that CLA partially exerts its action through potent antioxidant activity (Ha et al. 1990; Ip et al. 1991; Chin et al. 1994) . However, there are some discrepancies between the antioxidant efficacy of CLA and its anticarcinogenic potency (Ip et al. 1991; van den Berg et al. 1995) . The observed biological activity of CLA may also be mediated through enhanced immune function or by other regulatory metabolic mechanisms such as eicosanoid metabolism or lipid peroxidation. CLA modulates different aspects of cellular host defence such as mitogen-induced lymphocyte proliferation, lymphocyte cytotoxic activity, and macrophage bactericidal activity (Chew et al. 1997 ) as well as inhibiting prostaglandin E 2 synthesis (Belury and Kempa-Steczko 1997; Liu and Belury 1998; Bassaganya-Riera et al. 2001) .
Dietary CLA has been shown to increase growth performance and reduce fat deposition in pigs (Ostrowska et al. 1999 (Ostrowska et al. , 2003a and is being assessed as a growth modifier for use in commercial production (Dunshea et al. 2002) . CLA was reported to have immune enhancing properties in lactating sows and piglets (Bontempo et al. 2004 ), but studies addressing the effect of CLA supplementation on haematological and humoral responses in growing and finishing pig are still lacking. Since poor animal health is one of the biggest constraints to commercial pig production (Black et al. 2001) , the use of CLA consequently could be of benefit to the pig production industry. Therefore, the objective of this study was to investigate the effect of various doses of a commercial source of CLA (consisting of a mixture of at least 12 CLA isomers) on immunophenotyping and antibody concentrations in grower-finisher pigs. 
Materials and methods

Animals and handling
All procedures involving animals were approved by the Department of Primary Industries Animal Ethics Committee. Thirty female cross-bred (Large White × Landrace) pigs (av. initial weight 57 kg and 11 mm backfat at P 2 ) were selected from a relatively clean herd (minimal disease), blocked according to weight. The animals from each block were then randomly allocated to one of 6 dietary treatments (0, 1.25, 2.5, 5.0, 7.5, and 10.0 mg CLA-55/kg diet; Natural Lipids Ltd, Hovdebygda, Norway), with 5 blocks of 6 pigs (one of each treatment). This CLA, containing 55% CLA isomers, was prepared from sunflower oil. Thus, the CLA concentrations for the 6 diets were 0, 0.7, 1.4, 2.75, 4.1, and 5.5 g/kg diet, respectively. To ensure a homogenous mixture, CLA was mixed in soybean oil before adding to the basal diet. Diets were mixed every 2 weeks and the remaining CLA was stored at 4 • C to minimise oxidation. The qualitative and quantitative analysis of the CLA-55 and the oil content in the prepared diets was performed as described elsewhere Ostrowska et al. 2000) , using silver-ion HPLC. The isomer distribution of the CLA-55 is shown in Table 1 . The diets were formulated to be in excess of protein and lysine requirements for this class of pig (Dunshea et al. 1993) . Also, the experimental diets were formulated to contain amino acids relative to lysine in excess of the amino acid balance proposed as ideal (SCA 1987) . Details of the diet can be found elsewhere (Ostrowska et al. 2003a) .
Throughout the study, pigs were kept in individual pens and had free access to water from nipple drinkers and to their respective diet at all times. Pens were scraped and flushed 3 times a week to ensure a relatively clean environment. Fresh diet was provided daily to each pig as a top-up and the amount was recorded. On a weekly basis, all remaining food was removed and weighed. That value was subtracted from the total provided to get a weekly feed intake. Fresh feed was then provided again.
Pigs were weighed and ultrasonic back fat thickness at the P 2 region was determined weekly. Samples of blood were collected from all pigs (av. weight of 110 kg) at the end of 8 weeks of feeding with CLA. Blood was drawn by jugular venipuncture using 10-mL vacutainers with sodium heparin used as an anticoagulant. Blood was stored on ice before being assayed.
Cell counts
White blood cell counts were performed in whole blood, using a Sysmex K-4500 automated haematology analyser (TOA Medical Electronics Co., Kobe, Japan), and expressed as number of cells per mL of whole blood. Differential cell counts of neutrophils, lymphocytes, monocytes, basophils, and eosinophils were performed manually after staining of blood smears using the Diff-Quik (Lab Aids Pty Ltd, Narrabeen, Australia) stain method, and were expressed as number of cells per mL whole blood (Dhurandhar and Zorrilla 1988) . In some cases the basophil concentration values were below the level of detection and were assigned a value of 2.5 × 10 4 cells/mL.
T-cell population analysis
Labelling of CD4, CD8, and CD3 cells was performed in whole blood and analysed by flow cytometry. The primary antibodies used were mouse anti-porcine CD4 (IgG2b, cell line 74-12-4, VMRD, Pullman, WA), mouse anti-porcine CD3 (IgG1, cell line 8E6, VMRD), and mouse anti-porcine CD8 (IgG2a, cell line MIL-12, Serotec, Oxford, UK). The specificities of the anti-CD4 , anti-CD3 (Pescovitz et al. 1998) , and anti-CD8 (Saalmuller et al. 1994) have been previously described. Goat anti-mouse IgG Fc fragment, conjugated to FITC (ICN Biomedicals, Costa Mesa, CA), was used as the secondary antibody. All dilutions were performed in 0.15 M phosphate-buffered saline (PBS) and the optimal concentration of reagents determined by titration. Anti-CD4 was diluted 1/200, anti-CD8 1/20, anti-CD3 1/100, and FITC goat anti-mouse IgG 1/100. Diluted primary antibodies (50 µL) were applied to tubes containing 100 µL heparinised blood. Tubes were mixed and incubated on ice for 20 min. Cells were washed with PBS via centrifugation at 900G for 5 min at 4
• C. The supernatatant was discarded and cells resuspended in 50 µL of diluted secondary antibody. Tubes were mixed, incubated, and washed as described above. Erythrocytes were lysed by using FACSlyse (Becton Dickinson, Franklin Lakes, NJ) according to the manufacturer's instructions, after which cells were washed in PBS and resuspended in PBS containing 1% paraformaldehyde. Analysis of samples was performed by flow cytometry using a Becton Dickinson FACScan equipped with a 488-nm argon ion laser. Data were collected and analysed using the Becton Dickinson CellQuest software. Green fluorescence was collected on the FL1 channel with a logarithmic amplifier, and the lymphocyte population gated on the basis of forwards and side scatter properties. CD3, CD4, and CD8 data were expressed as number of cells × 10 6 /mL whole blood, and the ratio of CD4 to CD8 calculated.
Neutrophil function
The phagocytic capacity of neutrophils was measured in whole blood by flow cytometry using methods adapted from Perticarari et al. (1991) . Ten mL of sodium carbonate buffer (0.1 M, pH 9.5) containing 100 mg zymosan (Sigma, St Louis, MO) and 300 µg fluorescein isothiocyanate ([FITC], Sigma) were incubated for 2 h with gentle agitation at room temperature. FITC-labelled zymosan was then washed twice in sodium carbonate buffer and resuspended in 200 mL of 0.15 M phosphate-buffered saline, pH 7.2 (PBS); 20 mL of FITC-labelled zymosan was opsonised with 5 mL normal pig serum by incubation for 45 min at 37
• C, with gentle agitation. The solution was centrifuged at 800G and the pellet was resuspended in 20 mL PBS to produce serum-opsonised, FITC-labelled zymosan (FITC-zymosan). The optimal amount of FITC-zymosan for use in the phagocytic assay was determined by titration. Heparinised blood (100 µL), was mixed with 100 µL of FITC-zymosan and incubated at 37
• C for 45 min. Phagocytosis was stopped by placing the tubes on ice for 5 min. Erythrocytes were lysed using FACSlyse (Becton Dickinson) according to the manufacturer's instructions. Immediately prior to analysis, trypan blue was added to each tube to a final concentration of 100 µg/mL to quench the fluorescence of externalised particles. Flow cytometry was performed with a Becton Dickinson FACScan equipped with a 488-nm argon ion laser. Data were collected and analysed using the Becton Dickinson CellQuest software. Green fluorescence was collected on the FL1 channel with a logarithmic amplifier, and the neutrophil population gated on the basis of forwards and side scatter properties. Data were expressed as the percentage of the neutrophil population fluorescing green and thus undergoing phagocytosis.
Lymphocyte proliferation
The proliferative capacities of lymphocytes were measured in whole blood in 96-well plates with U-shaped wells. All dilutions and incubations were performed in the culture medium, termed whole blood wash (WBW), consisting of RPMI 1640 (Sigma) containing 10 000 IU penicillin, 10 mg streptomycin, and 29.2 mg L-glutamine (ICN Biomedicals, Costa Mesa, CA). Phytohaemagglutinin (PHA) (Sigma) was diluted to 8 µg/mL in WBW and 100 µL applied to half of the wells on the plate; the remaining wells (controls) were coated with 100 µL of WBW. Plates were stored at -20
• C until required. Heparinised blood was diluted 1/5 in WBW and 100 µL of diluted sample applied to each of 12 wells, consisting of 6 PHA wells and 6 control wells. Plates were incubated for 54 h at 37
• C, 85% humidity, and 5% CO 2 . Plates were pulsed with WBW containing 0.25 µCi [
3 H]-thymidine (Amersham Pharmacia Biotech, Piscataway, NJ) applied at 25 µL per well. Plates were incubated for a further 18 h. Proliferation and subsequent incorporation of tritiated thymidine was stopped by freezing; plates were stored at -20
• C until harvested. Plates were harvested onto filter mats (Wallac-Oy, Turku, Finland) using a combi harvester (Skatron, Lier, Norway). Filter mats were then stored in bags with beta plate scintillation fluid (Wallac-Oy), and counts per minute (cpm) determined using a betaplate counter (Wallac-Oy). The highest and lowest counts obtained within each set of 6 replicates were discarded, and the mean counts per minute calculated using the remaining 4 values. Results are expressed as a stimulation index, which is the mean cpm of stimulated wells divided by the mean cpm of control wells for each animal.
Antibody concentrations
Total serum levels of IgG were determined by sandwich ELISA. All dilutions and washes were performed in PBS containing 0.05% Tween-20 (PBS-T), and all incubations were conducted for 1 h at 37
• C unless otherwise stated. Microtitre plates ('Polysorp', Nunc, Roskilde, Denmark) were coated with mouse anti-pig IgG light chain (Serotec), diluted to 1/500 in 0.06 M carbonate buffer, pH 9.6; 100 µL were applied to each well and plates were incubated overnight at 4
• C. After coating, the plates were inverted and blocked with 1% gelatin in carbonate buffer, applied at 150 µL per well; plates were incubated, and washed 3 times. Standards of porcine IgG (Sigma) were titrated in doubling dilutions from 500 µg/mL to 0.49 µg/mL, and applied in duplicate at 100 µL per well. Porcine sera were diluted to 1/200 in PBS-T and applied in triplicate at 100 µL per well. After the application of sera and IgG standards, plates were incubated followed by 3 washes. Goat anti-porcine IgG (heavy and light chain specific) conjugated to horseradish peroxidase (HRP) (ICN) was diluted to 1/2500 and applied to plates at 100 µL per well. Plates were incubated followed by 3 washes. A substrate solution of 2-2 -azino-di(3-ethyl-benzthiazoline sulfonate) (ABTS, Kirkegaard & Perry Laboratories, Gaithersburg, ML) was applied according to the manufacturer's instructions, and the reaction stopped after 30 min at room temperature by the addition of Peroxidase Stop Solution (Kirkegaard & Perry Laboratories). Absorbance at 405 nm was read on a Spectramax 250 (Molecular Devices, Sunnyvale, CA), and antibody levels in serum calculated from the standard curve. Results were expressed as amount of IgG/mL serum.
Statistical analyses
Data were analysed as a randomised complete block design by ANOVA, suitable for a dose response curve with linear and quadratic effects being determined. The model included block, replicate, and dose of CLA. In addition, comparisons were made between diets containing either none or added CLA. For these analyses the model included block, replicate, and added CLA. Since much of the data exhibited heterogeneity in the variances, all data were log-transformed prior to analyses. Data are presented in tables as the log-transformed value with the back-transformed value in parentheses below.
Results
Effects of dietary CLA on growth performance have been presented elsewhere, but briefly, there was no effect of CLA on average daily gain, whereas there was a small improvement in feed : gain (-6%) with dietary CLA supplementation (Ostrowska et al. 2003a ). There was a quadratic response (P = 0.006) in carcass weight to dietary CLA such that carcass weight increased at intermediate levels but decreased at higher inclusion CLA levels. There was a pronounced linear (P = 0.002) decrease in back fat at the P2 site with increasing inclusion rates of CLA (Ostrowska et al. 2003a) .
The total white blood cell count was unaffected by dietary CLA (P = 0.60, Table 2 ). Neutrophil, lymphocyte, and monocyte counts were also unaffected by dietary CLA (P = 0.30, 0.73, and 0.58, respectively) ( Table 2 ). The ratio of neutrophils to lymphocytes, which is often used as an indicator of cellular responses to heat stress and immunological stressors, was also unaffected by dietary CLA (P = 0.31) (data not shown). The basophil count responded to level of CLA supplementation in a quadratic manner (P = 0.05, Table 2 ). The basophil count increased from 3.2 × 10 4 cells/mL blood for pigs fed basal diets to the highest level (6.5 × 10 4 cells/mL) of basophils recorded in blood of pigs fed 2.5 g CLA/kg diet. The levels were then further reduced as the rate of CLA increased in the diet until basophils were below the detectable limit (2.5 × 10 4 cells/mL) in pigs fed 10 g CLA/kg diet. A significant reduction (P = 0.003) of 58% in eosinophil count was recorded for pigs fed CLA-fortified diets (Table 2 ), even at the lowest level of supplementation (1.25 g/kg). At the highest level of CLA supplementation (10 g CLA/kg), eosinophil counts were reduced by as much as 65%. The CD3 and CD8 markers on the surface of lymphocytes measured in this study were not significantly different among the different dietary groups (P = 0.76 and 0.91, respectively, Table 3 ). The CD4 T-cells tended to be reduced in a linear fashion (P = 0.06) with increasing dietary CLA. The CD4 to CD8 ratio was not significantly altered by dietary CLA (P = 0.27). Neutrophil function tended to be improved (P = 0.07) with the increasing level of CLA supplementation (Table 4) . Lymphocyte proliferation in response to phytohaemagglutanin (PHA), a potent T-cell mitogen, was unaffected (P = 0.73) by dietary CLA. Serum IgG concentrations were significantly reduced (P < 0.001) by dietary CLA, with the response being evident at the lowest dose of supplemental CLA (Table 4 ). The serum IgG response to dietary CLA was quadratic in nature, with the nadir occurring at 7.5 g/kg CLA before increasing slightly at 10 g/kg CLA.
Discussion
In the present study, dietary CLA supplementation over the range 1.25-10 g/kg had no effect upon total white cells and specific types of leucocytes such as the neutrophils, lymphocytes, and monocytes. Previously, Cook et al. (1998) reported that growing pigs fed dietary CLA (9.5 g/kg of CLA-60) had elevated total white cell numbers, principally due to increased lymphocyte numbers. A trend towards an increase in white blood cells was also reported in nursery pigs fed CLA-60 and housed in clean or dirty environments (Bassaganya-Riera et al. 2001) . In contrast to these findings, Stangl et al. (1999) reported lower (P < 0.1) leucocyte counts in blood of heavier pigs (186 kg ± 4.0 kg) fed diets supplemented with 10 g/kg of CLA for 6 weeks than in pigs fed control diets. The CLA quality and diet composition as well as animals' age and environmental and immunological stressors to which the animals in different experiments were exposed are likely to be the main factors responsible for the differences between the results reported in these studies.
The in vitro incubation of lymphocytes collected from CLA-fed pigs failed to enhance the stimulation of the porcine lymphocyte proliferation when cells were induced with the T-cell mitogen, PHA. Although these results are in contrast to the reported findings of Chew et al. (1997) , the discrepancy could be due to the differences in the amount of physiological CLA present in the culture media and the level of CLA found in blood collected from CLA-fed pigs. Bassaganya-Riera et al. (2001) found no effect of dietary CLA supplementation in cells proliferating in response to Con-A addition into the media. However, unstimulated wells containing lymphocytes from pigs fed CLA showed a linear increase (P = 0.04) with CLA dose in proliferative response on Day 14 of CLA supplementation compared with those of pigs fed a control diet.
In vitro studies have shown that CLA stimulates the cytotoxic activities of pig lymphocytes (Chew et al. 1997) . In the present study the expression of CD3 and CD8, the lymphocyte differentiation markers on the surface of lymphocytes, was largely unaffected by dietary CLA. CD3, a marker for all T-cells (lymphocytes associated with cell-mediated immunity), and CD8, a marker of cytoxic and suppressive T-cells, were similar among all dietary levels of CLA and controls. However, there was a decrease in the expression of CD4 marker (a group of T-cells called T-helper cells) in a dose-dependent manner. Bassaganya-Riera et al. (2001) reported that in the absence of antigenic stimulation, CLA supplementation (6.7, 13.3, 20 g/kg) resulted in significant expansion of CD8+ lymphocytes in nursery pigs grown in both dirty and clean environments. The decrease in CD4+ lymphocytes was more pronounced in clean-housed piglets. Consequently, the percentages of CD4-CD8+ cells were increased as a result of CLA supplementation, with greater numbers reported in pigs in the clean room.
CLA-fed pigs in general were also found to have less than half of the blood eosinophils of pigs fed basal diets. The level of eosinophils was reduced in a dose-dependent manner, with the lowest levels observed in pigs fed the highest level of dietary CLA (10 g/kg). Although eosinophils represent only approximately 1% of peripheral blood leukocytes, they play a central pro-inflammatory and immunoregulatory role in various immune disorders. The growth and differentiation of eosinophils are controlled by the cytokine interleukin-5 (IL-5) (Coffman et al. 1989 ) and the present data suggest that CLA could regulate infiltrating CD4 + T-cells, which in turn modulate peripheral eosinophils that facilitate allergic inflammation.
Plasma basophil levels responded to CLA in a quadratic fashion, with the highest levels observed in pigs fed 2.5 g CLA-55/kg diet, whereas basophils were below the detection limit in pigs fed the highest level of CLA. Basophils are associated with the immediate immune response to external antigens and their increasing level would indicate that the CLA-pigs are less challenged by the environment. Like mast cells, when triggered by an antigen, basophils undergo rapid activation, degranulation, and release of bioactive mediators involved in the allergic reaction (Jelinek 2000) . The levels of prostaglandin E 2 (PGE 2 ), one such mediator, have been previously reported to be reduced by dietary CLA (Sugano et al. 1997 (Sugano et al. , 1998 . The peritoenal exudate cells, which reflect mast cell degranulation by a receptor-independent pathway, isolated from rats fed 0.5 or 1% CLA, were reported to be unaffected (Sugano et al. 1998) . CLA was shown to reduce the release of PGE 2 and leukotriene B4 from antigen-challenged lung, trachea, and bladder in the guinea pig (Whigham et al. 1999) .
It is known that serum immunoglobulins play a significant role in the recognition of foreign antigens, the hallmark of the specific adaptive immune response known as humoral immunity. IgG antibodies bind to antigenic determinants on an invading bacterial cell, deliver the bacterium to a macrophage, and activate the phagocytotic process. In the present study, the level of IgG decreased in a quadratic fashion (P < 0.001), and this reduction could be due to lower CD4 levels at lower concentrations of CLA. However, the ability of the macrophages to perform phagocytosis was not determined in this study. Chew et al. (1997) reported an increase in the in vitro killing activity of murine macrophages in the presence of CLA, but the phagocytic activity of peritoneal macrophages was decreased (P < 0.05-0.01) by high concentrations of CLA (3.57-7.14 × 10 −5 M). An increase in phytohaemaglutinin (PHA)-stimulated blastogenesis was also noted in CLA-fed chicks challenged with lipopolysaccharide (Cook et al. 1993) and mice fed CLA (Miller et al. 1994) . A 1.5-fold increase in PHA-P-induced spleen lymphocyte blastogenesis over basal was observed for CLA-fed mice (Miller et al. 1994) . In 2 feeding experiments, CLA added at 0.5% to the diet of chicks or rats decreased the weight loss of these animals in response to Escherichia coli LPS challenge (Cook et al. 1993) . Similarly, in the present study, the growth performance was maximised and IgG levels minimised at intermediate doses of CLA despite the fact that stimulation of the immune system has been reported to result in a decrease in growth (Klasing and Korver 1997) . However, it is important to recognise the multifaceted nature of the immune response and its effects upon growth performance. The work of Klasing and Korver (1997) refers to stimulation of the pro-inflammatory cytokine and stress hormone axis, causing stimulation of cellular immune responses. The negative effects of immune stimulation upon growth rate in livestock invariably refer to cellular and inflammatory responses rather than to antibody. Thus, it appears that effects of immune stimulation upon growth performance are a fine balance between increased maintenance requirements and the negative growth effects of succumbing to disease or pathogenic invasion.
The change in cellular fatty acid profiles due to dietary CLA could also be one of the explanations for the ability of CLA to induce some of the above-described responses. For example, the major bioactive fatty acid components of fish oil, eicosapentaenoate (EPA) and decosahexaenoate (DHA), have been shown to modulate immune function in rats (Miller et al. 1994) . EPA has been shown to depress arachidonic-acid-derived PGE 2 synthesis in peritoneal leukocytes from rats. This phenomenon has been partially attributed to the ability of fish oil to block the cyclooxygenase pathway, thereby decreasing PGE 2 synthesis and altering the ability of PGE to negatively feed back on IL-1 synthesis (Miller et al. 1994) . Similarly, the change in fatty acid composition in specific tissues due to dietary CLA supplementation has been reported in rodents (Cook et al. 1993; Sugano et al. 1997; Yurawecz et al. 1998) . A significant reduction in arachidonic acid in muscle and adipose tissue was observed in the CLA-fed pigs (Ostrowska et al. 2003b ); hence, it is possible that CLA may exert an effect on the immune system by altering product formation of either the cyclooxygenase or lipoxygenase pathway. Since cytokine production by macrophages is regulated by eicosanoids and since dietary lipids affect eicosanoid production, it might be expected that dietary lipids such as CLA affect cytokine production.
Although the present study demonstrates clear differences in some haematological and humoral responses to dietary CLA, multiple measurements need to be made to measure the true dynamics of these responses. It should also be noted that the CLA isomer composition used in different studies may have an effect on the measured responses since different isomers may modulate different immunological parameters (Yamasaki et al. 2003) . Furthermore, some of the current investigations involve CLA present in the methyl ester, rather than in the free acid form as used in the present study, and there may be further differences in response between these forms of CLA.
The immune function response to CLA under more challenging conditions needs to be determined in the future. The most pronounced effects of CLA were expressed in the number of eosinophils and basophils found. Because respiratory disease is a primary cause of economic loss in animal agriculture (Turek et al. 1994) , CLA supplementation could be of some benefit to the pig industry. The effects of CLA on some functions of porcine lung immune cells should be examined in the future.
